维普中文期刊产品整合服务
147篇 您的检索式:作者名="Hartmann O"
    题名 作者 年代 出处 被引量
1Protective action of glutamine in rats with severe acute liver failure显示文摘BACKGROUND Severe acute liver failure(SALF) is a rare, but high-mortality, rapidly evolving syndrome that leads to hepatocyte degeneration with impaired liver function.Thioacetamide(TAA) is a known xenobiotic, which promotes the increase of the formation of reactive oxygen species. Erythroid 2-related factor 2(Nrf2) activates the antioxidant protection of cells. Studies have evidenced the involvement of inflammatory mediators in conditions of oxidative stress.AIM To evaluate the antioxidant effects of glutamine on Nrf2 activation and NFκBmediated inflammation in rats with TAA-induced IHAG.METHODS Male Wistar rats(n = 28) were divided into four groups: control,control+glutamine, TAA, and TAA + glutamine. Two TAA doses(400 mg/kg)were administered intraperitoneally, 8 h apart. Glutamine(25 mg/kg) was administered at 30 min, 24 h, and 36 h. At 48 h, blood was collected for liver integrity analysis [aspartate aminotransferase(AST), alanine aminotransferase(ALT), and alkaline phosphatase(ALP)]. The liver was harvested for histology and assessment of oxidative stress [thiobarbituric acid-reactive substances(TBARS), catalase(CAT), glutathione peroxidase(GPx), glutathione S-transferase(GST), glutathione(GSH), Nrf2, Kelch-like ECH-associated protein 1(Keap1),NADPH quinone oxidoreductase1(NQO1), superoxide dismutase(SOD)] and inflammatory process.RESULTS TAA caused disruption of the hepatic parenchyma, with inflammatoryinfiltration, massive necrosis, and ballooning degeneration. Glutamine mitigated this tissue damage, with visible regeneration of hepatic parenchyma; decreased TBARS(P < 0.001), GSH(P < 0.01), IL-1β, IL6, and TNFα levels(P <0.01) in hepatic tissue; and decreased blood levels of AST, ALT, and ALP(P <0.05). In addition, CAT, GPx, and GST activities were restored in the glutamine group(P<0.01, P <0.01, and P <0.001, respectively vs TAA alone). Glutamine increased expression of Nrf2(P < 0.05), NQO1, and SOD(P < 0.01), as well as levels of IL-10(P <0.001), while decreasing expression of Keap1, TLR4, NFκB(P < 0.001), COX-2 and iNOS,(P < 0.01), and reducing NO_2 and NO_3 levels(P < 0.05).CONCLUSION In the TAA experimental model of IHAG, glutamine activated the Nrf2 pathway,thus promoting antioxidant protection, and blunted the NFκB-mediated pathway, reducing inflammation.Elizangela G Schemitt Renata M Hartmann Josieli R Colares Francielli Licks Jéferson O Salvi Cláudio A Marroni Norma P Marroni 2019World Journal of Hepatology2019,11,3:5
2Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial显示文摘Gunnar Folprecht Thomas Gruenberger Wolf O Bechstein Hans-Rudolf Raab Florian Lordick J?rg T Hartmann Hauke Lang Andrea Frilling Jan Stoehlmacher Jürgen Weitz Ralf Konopke Christian Stroszczynski Torsten Liersch Detlev Ockert Thomas Herrmann Eray Goekkurt 2010Lancet Oncology2010,,1:3
3On the temperature dependence of the fatigue and damage behavior of a particulate reinforced metal matrix composite显示文摘Biermann H Kemnitzer M Hartmann O 2001Mater SciEng A2001,319,:2
4Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty显示文摘Kordonouri O Hartmann R I)eiss D 2005Arch Dis Child2005,90,4:1
5Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocareinoma: a prospective multicentre phase II trial显示文摘Nehls O Oettle H Hartmann J T 2010Br J cancer2010,98,2:1
6Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: A prospective multicentre phase Ⅱ trial显示文摘Nehls O Oettle H Hartmann JT 2008Br J Cancer2008,98,:1
7Cyclohex-1-ene carboxylic acids:synthesis and biological evaluation of novel inhibitors of human 5α-reductase显示文摘Baston E Salem O Hartmann R W 2003Arch Pharm Pharm Med Chem2003,1,:1
8Sensor augmented pump therapy from onset of type 1diabetes:late follow‐up results of the pediatric onset study显示文摘Kordonouri O Hartmann R Pankowska E 2012Pediatric diabetes2012,13,7:1
9Carboxymethyl cocoyam starch:synthesis, characterisation and influence of reaction parameters 显示文摘Lawal O S Lechner M D Hartmann B 2007Starch/Starke2007,59,5:1
10Early domesticated fig in the Jordan Valley显示文摘Kislev M E Hartmann A Bar Yosef O 2006Science2006,312,:1
11Simulation and Analysis of Different Adiabatic Compressed Air Energy Storage Plant Configurations 显示文摘Hartmann N VShringer O Kruck C 2012Applied Energy2012,93,:1
12DNA methylation markers predict outcome in node-positive,estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy显示文摘Hartmann O Spyratos F Harbeck N 2009Clin Cancer Res2009,15,1:1
13Protection or nonprotection in carotid stent angioplasty: the influence of inteentional techniques on outcome data from the SPACE Trial显示文摘Jansen O Fiehler J Hartmann M 2009Stroke2009,40,3:1
14The influence of the free surface on the fracture of alumina particles in an Al-Al2O3 metal-matrix composite 显示文摘BORBELY A BIERMANN H HARTMANN O 2003Computational Materials Science2003,26,:1
15Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes显示文摘Brendel C Kuklick L Hartmann O 2005Gene Expr2005,12,46:1
16Persistent hypoglossal artery' MRI,MRA and digital subtraction angiorgraphy显示文摘Hahnel S Hartmann M Jansen O 2001Neuroradiology2001,43,:1
17Evaluation of re- sponse in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment 显示文摘AMaksimovie O Schraml C Hartmann IT 2010JR Am J Roentgenol2010,194,1:1
18Angioplasty and stenting of intracranial stenosis显示文摘 Janseh O 2005Curr Opin Neurol2005,18,:1
19Natural course of autoimmune thyroiditis in type 1 diabetes, association with gender, age, diabetes duration, and puberty显示文摘Kordonouri O Hartmann R Deiss D 2005Arch Dis Child2005,90,4:1
20Biomimetic crystallization of calcium carbonate spherules with controlled surface structures and sizes by doublehydrophilic block copolymers显示文摘Yu S H C(o)lfen H Hartmann J 0,,08:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费